These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 12485893)

  • 1. Role of Histone Deacetylase Inhibitor in Diabetic Painful Neuropathy.
    Thakur V; Gonzalez MA; Parada M; Martinez RD; Chattopadhyay M
    Mol Neurobiol; 2024 Apr; 61(4):2283-2296. PubMed ID: 37875708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling.
    Abdelkader NF; Elbaset MA; Moustafa PE; Ibrahim SM
    Arch Pharm Res; 2022 Jul; 45(7):475-493. PubMed ID: 35767208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of Jiaweibugan decoction against diabetic peripheral neuropathy.
    Wang Y; Chen Z; Ye R; He Y; Li Y; Qiu X
    Neural Regen Res; 2013 Apr; 8(12):1113-21. PubMed ID: 25206405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of trigonelline on experimental diabetic peripheral neuropathy.
    Zhou JY; Zhou SW
    Evid Based Complement Alternat Med; 2012; 2012():164219. PubMed ID: 23304193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice.
    Sharma R; Buras E; Terashima T; Serrano F; Massaad CA; Hu L; Bitner B; Inoue T; Chan L; Pautler RG
    PLoS One; 2010 Oct; 5(10):e13463. PubMed ID: 20976160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function.
    Du Y; Tang J; Li G; Berti-Mattera L; Lee CA; Bartkowski D; Gale D; Monahan J; Niesman MR; Alton G; Kern TS
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2158-64. PubMed ID: 20071676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy.
    Adhikary L; Chow F; Nikolic-Paterson DJ; Stambe C; Dowling J; Atkins RC; Tesch GH
    Diabetologia; 2004 Jul; 47(7):1210-1222. PubMed ID: 15232685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the pathogenesis of diabetic neuropathy.
    Obrosova IG
    Curr Diab Rep; 2003 Dec; 3(6):439-45. PubMed ID: 14611738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases.
    Yasuda S; Sugiura H; Tanaka H; Takigami S; Yamagata K
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):45-59. PubMed ID: 20812905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p38 MAP kinase corrects biochemical and neurological deficits in experimental diabetic neuropathy.
    Agthong S; Tomlinson DR
    Ann N Y Acad Sci; 2002 Nov; 973():359-62. PubMed ID: 12485893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.
    Price SA; Agthong S; Middlemas AB; Tomlinson DR
    Diabetes; 2004 Jul; 53(7):1851-6. PubMed ID: 15220210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy.
    Purves T; Middlemas A; Agthong S; Jude EB; Boulton AJ; Fernyhough P; Tomlinson DR
    FASEB J; 2001 Nov; 15(13):2508-14. PubMed ID: 11689477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.
    Middlemas A; Delcroix JD; Sayers NM; Tomlinson DR; Fernyhough P
    Brain; 2003 Jul; 126(Pt 7):1671-82. PubMed ID: 12805110
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.